These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16125466)

  • 1. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
    Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
    Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?
    Clarêncio J; de Oliveira CI; Favali C; Medina O; Caldas A; Costa CH; Costa DL; Brodskyn C; Barral A; Barral-Netto M
    Int Immunol; 2009 Feb; 21(2):137-44. PubMed ID: 19088063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis.
    Bimal S; Singh SK; Sinha S; Pandey K; Sinha PK; Ranjan A; Bhattacharya SK; Das P
    Exp Parasitol; 2008 Feb; 118(2):238-46. PubMed ID: 17904553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
    Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
    APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis.
    Ganguly S; Das NK; Panja M; Pal S; Modak D; Rahaman M; Mallik S; Guha SK; Pramanik N; Goswami R; Barbhuiya JN; Saha B; Chatterjee M
    J Infect Dis; 2008 Jun; 197(12):1762-71. PubMed ID: 18444882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome.
    Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Correa-Oliveira R
    Scand J Immunol; 2005 Nov; 62(5):487-95. PubMed ID: 16305646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8
    Rodrigues LS; Barreto AS; Bomfim LGS; Gomes MC; Ferreira NLC; da Cruz GS; Magalhães LS; de Jesus AR; Palatnik-de-Sousa CB; Corrêa CB; de Almeida RP
    Front Immunol; 2021; 12():773983. PubMed ID: 34777391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
    Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
    Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic classification of human CD4+ T cell subsets and their differentiation.
    Okada R; Kondo T; Matsuki F; Takata H; Takiguchi M
    Int Immunol; 2008 Sep; 20(9):1189-99. PubMed ID: 18635582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profile of t lymphocytes from peripheral blood and bronchoalveolar lavage fluid in patients with active pulmonary tuberculosis.
    Boras Z; Juretić A; Gagro A; Pavelić Lj
    Scand J Immunol; 2007 Mar; 65(3):257-64. PubMed ID: 17309780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
    Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
    Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.
    Rosas LE; Satoskar AA; Roth KM; Keiser TL; Barbi J; Hunter C; de Sauvage FJ; Satoskar AR
    Am J Pathol; 2006 Jan; 168(1):158-69. PubMed ID: 16400019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis.
    Cillari E; Milano S; Dieli M; Maltese E; Di Rosa S; Mansueto S; Salerno A; Liew FY
    J Immunol; 1991 Feb; 146(3):1026-30. PubMed ID: 1824848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of CD62L/CD45RB CD4+ and CD8+ lymphocyte subsets in hepatic and splenic tissues during murine visceral leishmaniasis.
    Gomes-Pereira S; Rodrigues OR; Santos-Gomes GM
    Immunol Lett; 2004 Aug; 95(1):63-70. PubMed ID: 15325799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.